BR Pharm, a regenerative medicine company, said it would present "Minimizing Procedural Pain and Maintaining Effectiveness" related to HP VITARAN, a skin booster using PN (Polynucleotide Sodium), at APS (AESTHETIC PLASTIC SURGERY) 2024, which will be held at the Grand InterContinental Seoul Parnas S
Myongji Hospital has begun performing TAVI (transcatheter aortic valve implantation), one of the most difficult cardiovascular procedures.The hospital was certified as a TAVI provider by the Ministry of Health and Welfare last year and has since been performing TAVI procedures in earnest, with Profe
After posting strong growth last year, Boryung aims to continue its momentum this year and join the “Trillion Won Club.” The company's confidence is fueled by increased sales across all business areas and success in the anticancer area.Boryung CEO Chang Doo-hyun (Daniel Chang) recently met with repo
"Taking Sugatree is like catching two birds with one stone, as it offers both ease of administration and cost-effectiveness."Dong-A ST's employees at the Diabetes Division of the Marketing 2 team of the ETC Business Headquarters said so in unison.Sugatree XR Tablet is a diabetes treatment combinatio
Led by homegrown anticancer drug Leclaza (lazertinib), Yuhan Corp. will continue its quest to become one of the top 50 global pharmaceutical companies this year. Yuhan aims to become one of the top 50 global pharmaceutical companies by 2026, its 100th founding anniversary.Yuhan Corp. CEO Cho Wook-je
Myongji Hospital has recruited Professor Park Joong-won of the National Cancer Center, an authority on liver cancer treatment who has identified the effectiveness of radiation (proton) therapy "for the first time worldwide."Professor Park, who started treatment at the Gastroenterology Department in
Samsung Medical Center (SMC) held a workshop last month for 13 Thai nephrologists and critical care physicians who visited to learn about the latest Continuous Renal Replacement Therapy (CRRT).CRRT is gaining recognition for its hemodynamic stability, allowing continuous treatment of patients experi
Type 1 diabetes is still misunderstood because of its name. Type 1 is often treated the same way as type 2 diabetes, which is a well-known, chronic disease of older adults. Unsurprisingly, diabetes policies have been created without taking into account the unique characteristics and circumstances of
AriBio said Wednesday that it has released the results of additional phase 2 analyses of AR1001, an oral treatment for Alzheimer's disease, at the 2023 Clinical Trials on Alzheimer's Disease (CTAD) in Boston, Mass. The investigational drug is being tested in a global phase 3 clinical trial.The compa
Cryoballoon (CB) catheter ablation is a treatment for atrial fibrillation (AF), the most common type of arrhythmia. It has been reported to have a short procedure time and low complication rate, and its effectiveness and safety have been confirmed in several global clinical studies.Clinical studies
"Reasons are aplenty for biopharmaceutical companies to invest in Uijeongbu. For instance, the city's proximity to Seoul makes it easy to attract high-quality human resources, the presence of university hospitals nearby facilitates the conduct of clinical trials, and the ability to purchase large pa
Samsung Medison will showcase its AI-based diagnostic aids at the 33rd annual congress of the International Society of Ultrasound in Obstetrics & Gynecology (ISUOG 2023), at COEX, southern Seoul, from Oct. 17 to 19.ISUOG, one of the most important societies in the ultrasound in obstetrics and gyneco
AriBio, a biotech firm specializing in medicines for neurodegenerative and infectious disease, said Wednesday it has signed a memorandum of understanding for strategic collaboration with Shanghai Pharmaceuticals, the second-largest pharmaceutical distributor in China.The main contents of the MOU inc
The Korean Society of Radiology (KSR) will host the Korean Congress of Radiology 2023 (KCR 2023), its 79th annual conference, at COEX, southern Seoul, from Sept. 20 to 23.Under the slogan “Exploring Beyond the Horizon,” the congress has attracted 499 pre-registrations from abroad. According to the s
Amid the rapid popularization of botulinum toxin for cosmetic procedures, the number of men who have the procedure is also increasing, data showed.According to the American Society of Plastic Surgeons, more than 260,000 botulinum toxin treatments were performed on men in 2020. The situation in Korea
Heart failure poses significant challenges in both diagnosis and treatment. However, in recent times, the landscape of managing this condition has undergone a transformative shift with the introduction of numerous new drugs. A notable example is the use of sodium-glucose co-transporter-2 (SGLT-2) in
"We must keep the hard-won flame alive. It is imperative to increase the self-reliance in active pharmaceutical ingredients (API) to establish pharmaceutical sovereignty by improving the self-sufficiency rate of medicines."Han Ssang-soo, who chairs the Special Committee for API within the Korea Phar
The Ministry of Food and Drug Safety (MFDS) issued an administrative notice Friday that it would establish, revise and abolish 166 Korean Standards (KS) in the medical devices area and receive comments until Aug. 13.The notice is designed to improve the quality and safety of Korean medical devices a
CGBio, a Korean regenerative biopharmaceutical company, said Tuesday that Novomax Fusion, aitsnext-generation osteo-active bioglass ceramic cage, has received approval from Japan’s Pharmaceutical and Medical Devices Agency (PMDA).According to CGBio, Novomax Fusion is a synthetic glass-ceramic spacer
“I met a patient who had a previously implanted heart valve that had reached the end of its useful life and needed reoperation. He had had four previous heart surgeries. So, his face turned gloomy when I told him I would do it again, because he knew how painful it would be. I performed a percutaneou
